Skip to main content
. 2023 Jan 6;26:100573. doi: 10.1016/j.lanepe.2022.100573

Fig. 1.

Fig. 1

Overall survival in systemically treated patients diagnosed with HR+/HER2− ABC per period of diagnosis. mOS, median overall survival; CI, confidence interval.